Sort
8,912 grants matching “sars cov 2”
Monoclonal antibody isolation and characterization for COVID-19 Effort
$428,418Rosemarie Mason · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Observation and quantification of respiratory droplets by laser light scattering
$427,945Adriaan Bax · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union
$427,763Dong Wang · University Of Nebraska Medical Center · R01 · FY2024 · AR
Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union
$427,763Dong Wang · University Of Nebraska Medical Center · R01 · FY2025 · AR
Modular synthesis of antibiotic and anticancer classes of natural products
$427,433Ian Bass Seiple · University Of California, San Francisco · R35 · FY2023 · GM
Identification, structures and ontogenies of SARS-CoV-2 antibodies
$427,403Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Development of Broad-Spectrum Antiviral Therapeutics by Destabilizing the Main Protease of Coronaviruses
$427,052Weiping Tang · University Of Wisconsin-Madison · R21 · FY2020 · AI
CNS-mediated fever after Adolescent Intermittent Ethanol
$426,682Terrence Deak · State University Of Ny,Binghamton · R01 · FY2025 · AA
CNS-mediated fever after Adolescent Intermittent Ethanol
$426,682Terrence Deak · State University Of Ny,Binghamton · R01 · FY2024 · AA
Integrating opportunistic data into respiratory disease models to enhance surveillance, explain seasonality, and reveal spatial transmission landscapes
$426,660Shweta Bansal · Georgetown University · R35 · FY2025 · GM
Developing three-dimensional antisense oligonucleotide drugs against COVID-19
$426,633Feng Guo · University Of California Los Angeles · R01 · FY2021 · AI
Project 3: Serological Interactions with the Mucosal Innate Immune System Regulates COVID-19 Associated Tissue Damage.
$426,631Matthew C Wolfgang · Univ Of North Carolina Chapel Hill · U54 · FY2022 · CA
Neuroprotective Potential of Vaccination Against SARS-CoV-2 in Nonhuman Primates
$426,250James B Daunais · Wake Forest University Health Sciences · R21 · FY2023 · NS
Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas
$426,004Diana Carolina Vanegas-Gamboa · Clemson University · U01 · FY2022 · AA
Dealing with antibiotic resistance: antisense technology
$426,000Marcelo E Tolmasky · California State University Fullerton · R15 · FY2022 · AI
Dissecting the mechanism of altered immune responses during obesity
$425,647Elizabeth Ann Leadbetter · University Of Texas Hlth Science Center · R21 · FY2025 · AI
Einstein-Mount Sinai Diabetes Research Center
$425,000Jeffrey E Pessin · Albert Einstein College Of Medicine · P30 · FY2023 · DK
Mount Sinai Health System Kidney Precision Medicine Project
$425,000Kirk N Campbell · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · DK
SARS-CoV-2 and Autophagy
$424,875William T Jackson · University Of Maryland Baltimore · R21 · FY2020 · AI
Neuroimaging and Behavioral Studies to Assess For Neuroinflammation in COVID-19 During Convalescence
$424,875Linda Chang · University Of Maryland Baltimore · R21 · FY2021 · NS
Using dynamic network models to quantitatively predict changes in binding affinity/specificity that arise from long-range amino acid substitutions
$424,111Sefika Banu Ozkan · Arizona State University-Tempe Campus · R01 · FY2022 · GM
Synergistic effects of silica exposure, virus infection and genetic predisposition in systemic autoimmunity
$423,965Roberto G Baccala · San Diego Biomedical Research Institute · R01 · FY2021 · ES
CHARACTERIZATION OF INNATE AND ADAPTIVE IMMUNE RESPONSES INDUCED BY DIFFERENT HUMAN CORONAVIRUSES IN HUMAN PRIMARY SYSTEMS
$423,750Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI
Project-003
$423,750Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI
Identifying immune correlates of disease severity and novel immune drivers of pathogenicity to target in patients with COVID-19
$423,750Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · P30 · FY2020 · CA